Demonstrating Substantial Evidence of Effectiveness for Human Drug and Biological Products; Guidance for Industry; Draft Guidance
FDA-2019-D-4964-0077Other
Comments
2
Last activity Jul 31, 2026
Deadline
50 days
Closes Sep 23, 2026
Net supportiSupport minus oppose · campaigns included
—
Document
Details
The document's own metadata, straight from the source system.
- Title
- Demonstrating Substantial Evidence of Effectiveness for Human Drug and Biological Products; Guidance for Industry; Draft Guidance
Revision 1
- Posted
- Jun 24, 2026
- Comment period
- Jun 24, 2026 – Sep 23, 2026
- Topics
Analysis
Overview
What the public is saying — stance, who's commenting, and the issues they raise.
Include campaigns
Analyzed 0 of 2 comments
0%· analysis in progress
Stance breakdown
—
Net support
Not yet analyzed2
Who commented
Breakdown by commenter type.
Not yet analyzed
2
Comments over time
Weekly arrivals, stacked by stance.
Posted Jun 24, 2026Deadline Sep 23, 2026
Jul 27
Support0Oppose0Other0
Issues raised
The docket's canonical issues. Select one to browse its comments.
Issues are identified as comment analysis progresses — nothing tagged on this document yet.
Comments
Explorer
Every mirrored comment — filter by stance, campaign, or issue.
Filter:
- 2 comments from the past week
2 comments match your current view and arrived in the last week. Read this week's comments with stance, commenter type, and AI summaries on the paid plan.